Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Laboratory Corp of America Holdings (LH)

Laboratory Corp of America Holdings (LH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Diagnostics & Research Stocks to Buy on the Dip

The diagnostics and research industry has witnessed significant growth over the past couple years due to the pandemic-driven tailwinds, growing prevalence of chronic diseases, and rising adoption of advanced...

A : 124.41 (-1.25%)
LH : 249.15 (-0.14%)
WAT : 317.45 (-1.16%)
LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients

LabCorp's (LH) new assay is claimed to have shown a demonstrable clinical advantage in patients suffering from melanoma.

UNH : 497.56 (+1.11%)
LH : 249.15 (-0.14%)
ALKS : 28.35 (-3.24%)
MEDP : 133.32 (-0.30%)
Labcorp Launches New Test for People With Skin Cancer

Finding treatment options for skin cancer may become easier with the launch of a new test by Labcorp (NYSE: LH), a leading global life sciences company. The new test measures Lymphocyte-activation gene...

LH : 249.15 (-0.14%)
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection

Labcorp (NYSE: LH), a leading global life sciences company, today announced the receipt of Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a combined at-home collection...

LH : 249.15 (-0.14%)
Labcorp to Speak at the UBS 2022 Global Healthcare Conference

Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the UBS 2022 Global Healthcare Conference...

LH : 249.15 (-0.14%)
LabCorp (LH) Debuts At-home Collection Kit for Diabetes Testing

LabCorp's (LH) at-home collection kit makes it effortless for consumers to understand their diabetes risk and health status using an innovative and approved collection device.

UNH : 497.56 (+1.11%)
LH : 249.15 (-0.14%)
ALKS : 28.35 (-3.24%)
MEDP : 133.32 (-0.30%)
Labcorp Launches First-of-its-kind At-home Collection Device for Diabetes Risk Testing

There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes. Labcorp (NYSE: LH), a leading global life sciences company, is making screening...

LH : 249.15 (-0.14%)
Here's Why You Should Retain LabCorp (LH) Stock for Now

Investors are optimistic about LabCorp's (LH) better-than-expected earnings and robust segmental performance.

UNH : 497.56 (+1.11%)
LH : 249.15 (-0.14%)
AMN : 88.13 (+0.05%)
MEDP : 133.32 (-0.30%)
Labcorp Acquires Diagnostic Clinical Laboratory Services From AtlantiCare

Labcorp (NYSE: LH), a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New Jersey, today announced that they have closed a transaction to expand their...

LH : 249.15 (-0.14%)
Labcorp to Webcast Its Annual Meeting of Shareholders

Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 11, at 9:00 a.m. ET via the Labcorp Investor Relations...

LH : 249.15 (-0.14%)

Barchart Exclusives

2 Covered Call Ideas on Johnson & Johnson Stock
With markets looking increasingly volatile, investors might be more interested in generating income rather than capital gains. Johnson & Johnson (JNJ) is a solid defensive play that has held up well so far this year. JNJ also pays a healthy dividend with the current dividend yield sitting at 2.40%. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar